Risk of Stroke in Young Women and Two Prothrombotic Mutations: Factor V Leiden and Prothrombin Gene Variant (G20210A)

Mutation in blood coagulation factor V associated with resistance to activated protein C

1994 • 3,871 citations

A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis

1996 • 3,124 citations

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C.

1993 • 1,997 citations

Statistics with Confidence: Confidence Intervals and Statistical Guidelines.

1990 • 1,355 citations

Resistance to Activated Protein C as a Basis for Venous Thrombosis

1994 • 1,148 citations

Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy Men

1995 • 1,060 citations

Factor V Leiden (Resistance to Activated Protein C) Increases the Risk of Myocardial Infarction in Young Women

1997 • 383 citations

A Common Prothrombin Variant (20210 G to A) Increases the Risk of Myocardial Infarction in Young Women

1997 • 367 citations

Coagulation Studies, Factor V Leiden, and Anticardiolipin Antibodies in 40 Cases of Cerebral Venous Thrombosis

1996 • 278 citations

The prothrombin gene G20210A variant: prevalence in a U.K. anticoagulant clinic population

1997 • 172 citations

The prevalence of poor anticoagulant response to activated protein C (APC resistance) among patients suffering from stroke or venous thrombosis and among healthy subjects

1994 • 170 citations

Factor V Leiden Mutation in Cerebral Venous Thrombosis

1996 • 169 citations

Factor V Leiden mutation: An unrecognized cause of hemiplegic cerebral palsy, neonatal stroke, and placental thrombosis

1997 • 166 citations

Arg506GIn Factor V Mutation (Factor V Leiden) in Patients with Ischaemic Cerebrovascular Disease and Survivors of Myocardial Infarction

1995 • 162 citations

Factor V Gene Mutation Is a Risk Factor for Cerebral Venous Thrombosis

1996 • 146 citations

Factor V Leiden Gene Mutation and Thrombin Generation in Relation to the Development of Acute Stroke

1995 • 127 citations

Reduced Response to Activated Protein C Is Associated with Increased Risk for Cerebrovascular Disease

1996 • 126 citations

Use of Low-Dose Oral Contraceptives and Stroke in Young Women

1997 • 110 citations

Ischemic Stroke in Young Patients With Activated Protein C Resistance

1995 • 107 citations

Ischemic Stroke in the Elderly

1996 • 101 citations

Activated Protein C Resistance in Ischemic Stroke Not Due to Factor V Arginine ⁵⁰⁶ →Glutamine Mutation

1996 • 81 citations

Ischaemic stroke in infancy and childhood

1996 • 63 citations

The factor V Leiden mutation: Spectrum of thrombotic events and laboratory evaluation

1997 • 62 citations

Cerebral Venous Thrombosis and Activated Protein C Resistance

1996 • 62 citations

Factor V Leiden is not responsible for stroke in patients with sickling disorders and is uncommon in African Americans with sickle cell disease

1997 • 41 citations

Frequency of resistance to activated protein C due to factor V mutation in young patients with ischemic stroke.

1996 • 37 citations

Low Prevalence of the Factor V Leiden among Patients with Ischemic Stroke

1997 • 28 citations

Isolated cortical vein thrombosis and activated protein C resistance.

1996 • 18 citations

Fatal Cerebral Venous Sinus Thrombosis Associated with the Factor V Leiden Mutation and the Use of Oral Contraceptives

1995 • 18 citations

FV-ARG-506-GLN-Mutation-associated resistance to activated protein C in ischemic stroke

1995 • 14 citations

[Primary T lymphoma of the bladder in a HIV infected patient].

1995 • 5 citations

Deleted Work

1955 • 0 citations